c-Myc inhibitor 6

• UNSPSC Description:

  c-Myc inhibitor 6 (compound A102) is a c-Myc inhibitor. c-Myc inhibitor 6 decreases cancer cell viability and degrades c-Myc protein. c-Myc inhibitor 6 can be used for the research of c-Myc imbalance, such as cancer, cardiovascular diseases, and viral infection[1].

• Target Antigen:

  c-Myc

• Type:

  Reference compound

• Related Pathways:

  Apoptosis

• Applications:

  COVID-19-anti-virus

• Field of Research:

  Cancer; Infection; Cardiovascular Disease

• Assay Protocol:

  https://www.medchemexpress.com/c-myc-inhibitor-6.html

• Solubility:

  DMSO : 100 mg/mL (ultrasonic)

• Smiles:

  CC(C)C[C@@H](B(O)O)NC(CCNC(OCC1C2=CC=CC=C2C3=CC=CC=C31)=O)=O

• Molecular Weight:

  424.30

• References & Citations:

  [1]Tong, Youzhi, et al. C-myc protein inhibitor, preparation method therefor, and use thereof. WO2022089556. 2021.

• Shipping Conditions:

  Blue Ice

• Clinical Information:

  No Development Reported

• CAS Number:

  2768765-58-6